Publications

The CNODES network of researchers, trainees, and analysts conduct studies using administrative healthcare data in response to queries from Canadian regulators. The results of these studies are published in open-access academic journals. CNODES also publishes a selection of its methodological advances, knowledge translation initiatives, and trainee projects.

Wall-Wieler E, Robakis TK, Cesta CE, Masarwa R, Lyell DJ, Liu C, Platt RW, Carmichael SL. Antidepressant Use around Conception, Prepregnancy Depression, and Risk of Ectopic Pregnancy. Can J Psychiatry. 2020 Dec;65(12):845-853.

Gravel CA, Filion KB, Reynier PM, Platt RW.  Post-myocardial infarction statin exposure and the one-year risk of stroke: a modification to inverse propensity score weighting for the consistent estimation of marginal causal effects in the presence of outcome misclassification. Epidemiology. 2020 Nov;31(6):880-888.

Ukah UV, Platt RW, Potter BJ, Paradis G, Dayan N, He S, Auger N. Obstetric haemorrhage and risk of cardiovascular disease after three decades: a population-based cohort study. BJOG. 2020 Nov;127(12):1489-1497.

Yu OHY, Dell’Aniello S, Shah BR, Brunetti V, Daigle JM, Fralick M, Douros A, Hu N, Alessi-Severini S, Fisher A, Bugden SC, Ronksley PE, Filion KB, Ernst P, Lix LM, for the Canadian Network for Observational Drug Effect Studies (CNODES) Investigators. Sodium Glucose Co-transporter-2 Inhibitors and the Risk of Below-knee Amputation: a Multicenter Observational Study. Diabetes Care 2020 Oct;43(10):2444-2452.

Khosrow-Khavar F, Bouganim N, Filion KB, Suissa S, Azoulay L. Cardiotoxicity of Sequential Aromatase Inhibitors Use in Women with Breast Cancer. Am J Epidemiol. 2020 Oct 1;189(10):1086-1095.

Filion KB, Lix LM, Yu OHY, Dell’Aniello S, Douros A, Shah BR, St-Jean A, Fisher A, Tremblay E, Bugden SC, Alessi-Severini S, Ronksley PE, Hu N, Dormuth CR, Ernst P, Suissa S for the Canadian Network for Observational Drug Effect Studies (CNODES) Investigators. Sodium glucose cotransporter 2 inhibitors and risk of major adverse cardiovascular events: multi-database retrospective cohort study. BMJ. 2020 Sep 23;370:m3342.

Douros A, Lix LM, Fralick M, Dell’Aniello S, Shah BR, Ronksley PE, Tremblay E, Hu N, Alessi-Severini S, Fisher A, Bugden SC, Ernst P, Filion KB, for the Canadian Network for Observational Drug Effect Studies (CNODES) Investigators. Sodium-glucose co-transporter 2 inhibitors and the risk of diabetic ketoacidosis: A multicenter cohort study. Annals of Internal Medicine. 2020 Sep 15;173(6):417-425.

Fisher A, Fralick M, Filion KB, Dell’Aniello S, Douros A, Tremblay E, Shah BR, Ronksley PE, Alessi-Severini S, Hu N, Bugden SC, Ernst P, Lix LM, for the Canadian Network for Observational Drug Effect Studies (CNODES) Investigators. Sodium-glucose Cotransporter 2 Inhibitors and the Risk for Urosepsis – A Multi-site Prevalent New-user Cohort Study. Diabetes Obes Metab. 2020 Sep;22(9):1648-1658.

Giorgianni F, Ernst P, Dell’Aniello S, Suissa S, Renoux C. Beta 2 agonists and the incidence of Parkinson’s disease. Am J Epidemiol. 2020 Aug 1;189(8):801-810.

Wall-Wieler E, Robakis TK, Lyell DJ, Masarwa R, Platt RW, Carmichael SL. Benzodiazepine use before conception and risk of ectopic pregnancy. Hum Reprod. 2020 Jul 1;35(7):1685-1692.